Company Filing History:
Years Active: 2023-2025
Title: Judith Maria Ertle: Innovator in Medical Treatments
Introduction
Judith Maria Ertle is a prominent inventor based in Ingelheim am Rhein, Germany. She has made significant contributions to the field of medical treatments, particularly in the area of liver diseases. With a total of 2 patents, her work focuses on innovative solutions for serious health conditions.
Latest Patents
Ertle's latest patents include groundbreaking inventions aimed at treating portal hypertension. The first patent, titled "Soluble guanylate cyclase activators for treating portal hypertension," describes methods for treating patients with compensated cirrhosis. This invention involves administering a therapeutically effective amount of a soluble guanylate cyclase (sGC) activator or a pharmaceutically acceptable salt thereof to patients in need. The second patent, "Alkoxy pyrazoles as soluble guanylate cyclase activators," relates to compounds that can be used in the treatment of diseases alleviated by sGC activation. These include chronic liver diseases, Non-Alcoholic Steatohepatitis (NASH), cirrhosis, and portal hypertension.
Career Highlights
Judith Maria Ertle is associated with Boehringer Ingelheim International GmbH, a leading company in the pharmaceutical industry. Her work at this organization has allowed her to focus on developing innovative treatments that address critical health issues.
Collaborations
Ertle has collaborated with notable colleagues, including Jochen Huber and Ruediger Streicher. These partnerships have contributed to her success in advancing medical research and developing effective treatments.
Conclusion
Judith Maria Ertle's contributions to medical innovation, particularly in the treatment of liver diseases, highlight her role as a significant inventor in the pharmaceutical field. Her patents reflect her commitment to improving patient outcomes through innovative solutions.